DONOR SIMVASTATIN TREATMENT INFLUENCES TRANSCRIPTOMIC PROFILES OF EXTRACELLULAR VESICLES IN RECIPIENTS AFTER HEART TRANSPLANTATION. Issue 3 (September 2020)